Identificación de portadoras de distrofia muscular de Duchenne y Becker (DMD/DMB) mediante análisis de dosis génica y polimorfismo de ADN

Hernández, Patricia; Gómez, Yenny M; Restrepo, Carlos M.
Biomédica (Bogotá) ; 20(3): 228-37, sept. 2000. ilus, tab, graf
Artículo en Español | LILACS | ID: lil-278155

Documentos relacionados

  1. Muscular dystrophies.
  2. A Revisited Diagnosis of Collagen VI Related Muscular Dystrophy in a Patient with a Novel COL6A2 Variant and 21q22.3 Deletion.
  3. The many roles of dystroglycan in nervous system development and function: Dystroglycan and neural circuit development: Dystroglycan and neural circuit development.
  4. Oculopharyngodistal myopathy.
  5. Skin biopsy findings in megaconial congenital muscular dystrophy with psoriasiform lesions due to variants in CHKB.
  6. The CGG repeat expansion in RILPL1 is associated with oculopharyngodistal myopathy type 4.
  7. Non-coding CGG repeat expansion in <i>LOC642361/NUTM2B-AS1</i> is associated with a phenotype of oculopharyngodistal myopathy.
  8. Ablation of the carboxy-terminal end of MAMDC2 causes a distinct muscular dystrophy.
  9. Whole exome sequencing identifies a novel variant in the COL12A1 gene in a family with Ullrich congenital muscular dystrophy 2.
  10. Anoctamin 5 (ANO5) muscular dystrophy-three different phenotypes and a new histological pattern.